Result of Retail Offer
GENinCode Plc announced the successful closure of its WRAP Retail Offer, raising approximately £0.2 million through the issuance of 20,014,095 new Ordinary Shares at 1 pence per share. This brings the total gross proceeds from the overall Fundraising to approximately £4.1 million, conditional on the passing of resolutions at the General Meeting.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
GENinCode (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, is pleased to announce that the WRAP Retail Offer launched on 21 January 2026 has now closed, raising aggregate gross proceeds of approximately £0.2 million through the issuance of 20,014,095 new Ordinary Shares at the Issue Price of 1 pence per share.
Accordingly, conditional on the passing of the Resolutions at the General Meeting, the Company has have raised total gross proceeds of approximately £4.1 million in aggregate by way of the Fundraising.
Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released on 21 January 2026.
| Oberon Capital (Joint Bookrunner) Mike Seabrook / Adam Pollock / Aimee McCusker | Tel: +44 (0) 203 179 5300 corporatesales@oberoninvestments.com |
| Turner Pope Investments (TPI) Ltd (Joint Bookrunner) Guy McDougall / Andy Thacker | Tel: (0) 20 3657 0050 |
| Walbrook PR Limited | Tel: 020 7933 8780 or |
| Anna Dunphy | genincode@walbrookpr.com |
| Winterflood Retail Access Platform Sophia Bechev, Kaitlan Billings | WRAP@winterflood.com +44(0) 20 3100 0214 |
Further information on the Company can be found on its website at https://investors.genincode.com
The Company's LEI is 213800UX6TE7K65O2892.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.